Open-Label Extension of RPC1063 as Therapy for Moderate to Severe Ulcerative Colitis

Entyvio (Vedolizumab) Long Term Safety Study

A Safety and Efficacy Study of Relamorelin in Diabetic Gastroparesis

A Safety and Efficacy Study of Relamorelin in Diabetic Gastroparesis Study 04

Study for Participants With Ulcerative Colitis Previously Enrolled in Etrolizumab Phase II/III Studies

A Safety and Efficacy Study of Relamorelin in Diabetic Gastroparesis Study 03

Open-Label Extension and Safety Study for Patients With Crohn's Disease Previously Enrolled in the Etrolizumab Phase III Study GA29144

Study to Compare Oral PF-06651600, PF-06700841 and Placebo in Subjects With Moderate to Severe Ulcerative Colitis